Capstone Investment Advisors, LLC Abb Vie Inc. Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 138,500 shares of ABBV stock, worth $24.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

138,500

Previous 261,200 46.98%

Holding current value

$24.9 Million

Previous $44.8 Million 38.95%

% of portfolio

0.09%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $251,658 - $306,170	1,536 New	1,536 $303,000
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $918,965 - $1.05 Million	5,750 Added 2601.81%	5,971 $1.09 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $2.95 Million - $3.32 Million	-21,442 Reduced 98.98%	221 $34,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $4.61 Million - $5.34 Million	-34,510 Reduced 61.44%	21,663 $3.23 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $7.44 Million - $9.26 Million	56,173 New	56,173 $7.57 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $2.56 Million - $3.07 Million	-18,538 Reduced 99.89%	21 $3,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $206,549 - $236,898	-1,539 Reduced 7.66%	18,559 $2.49 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $423,181 - $538,002	3,075 Added 18.06%	20,098 $3.08 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $2.02 Million - $2.5 Million	15,285 Added 879.46%	17,023 $2.76 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $8.19 Million - $10.4 Million	-76,220 Reduced 97.77%	1,738 $235,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $4.55 Million - $5.16 Million	42,724 Added 121.26%	77,958 $8.41 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $3.67 Million - $4.09 Million	34,905 Added 10609.42%	35,234 $3.97 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $3.7 Million - $4.34 Million	-43,041 Reduced 99.24%	329 $29,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $152,194 - $190,427	-2,110 Reduced 4.64%	43,370 $3.84 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.21 Million - $1.46 Million	19,288 Added 73.64%	45,480 $3.44 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $601,549 - $768,920	9,156 Added 53.75%	26,192 $1.91 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $774,794 - $911,894	10,044 Added 143.65%	17,036 $1.37 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.17 Million - $1.45 Million	-15,086 Reduced 68.33%	6,992 $645,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.14 Million - $1.26 Million	12,767 Added 137.12%	22,078 $2.09 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $835,941 - $989,107	9,311 New	9,311 $863,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Abb Vie Inc. Transaction History